0001104659-20-083754.txt : 20200715
0001104659-20-083754.hdr.sgml : 20200715
20200715163907
ACCESSION NUMBER: 0001104659-20-083754
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200713
FILED AS OF DATE: 20200715
DATE AS OF CHANGE: 20200715
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hudson Frederick M.
CENTRAL INDEX KEY: 0001438462
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35518
FILM NUMBER: 201029457
MAIL ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001356576
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-838-2500
MAIL ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060317
4
1
a4.xml
4
X0306
4
2020-07-13
0
0001356576
SUPERNUS PHARMACEUTICALS, INC.
SUPN
0001438462
Hudson Frederick M.
C/O SUPERNUS PHARMACEUTICALS, INC.
9715 KEY WEST AVENUE
ROCKVILLE
MD
20850
1
0
0
0
Common Stock
2020-07-13
4
M
0
8750
2.56
A
18961
D
Common Stock
2020-07-13
4
S
0
920
24.44
D
18041
D
Director Stock Option (Right to Buy)
2.56
2020-07-13
4
M
0
8750
0
D
2011-11-16
2020-11-16
Common Stock
8750
0
D
Transaction made pursuant to a 10b5-1 trading plan adopted June 12, 2020.
Includes 5,211 restricted stock units previously reported that will be settled in common stock upon vesting, such vesting to occur on February 21, 2021.
/s/ Gregory S. Patrick, as attorney-in-fact
2020-07-15